284. High-Efficiency Targeted Introduction of an Anti-CD19 CAR Into the CCR5 Locus in Primary Human T Cells

Malika Hale(University of Washington), David J. Rawlings(Center for Infectious Disease Research), Jaya Sahni(Dallas VA Medical Center), Andrew M. Scharenberg(CTI BioPharma (Italy)), Guillermo S. Romano Ibarra, Iram Khan
Molecular Therapy
May 1, 2015
Cited by 0


Related Papers